Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients
A clinical trial from the Medical University of Vienna is evaluating Torque Teno Virus as a biomarker to predict response to immune checkpoi…
-
CLINICAL_TRIALS research · 2025-05-12Clinical Trial Update: NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC [Phase 1]
A Phase 1 clinical trial is evaluating NAD+ precursor NMN in combination with radioimmunotherapy for advanced non-small cell lung cancer. Th…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
A clinical trial by JaxBio Ltd is evaluating a novel epigenetic mapping approach in cell-free DNA for detecting lung cancer, and the study i…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors [Phase 1]
Phase Ib study of HS-10370 in combination with other anti-cancer therapies for advanced solid tumors, including colorectal cancer and non-sm…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 neoadjuvant study evaluating dupilumab plus cemiplimab in patients with early-stage resectable non-sma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C [Phase 2]
Phase 2 clinical trial evaluating sotorasib for KRAS G12C-mutated non-small cell lung cancer in patients who have received prior therapy; th…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008) [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of Balstilimab in combination with Botensilimab for non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study [Phase 2]
A Phase II, single-arm study evaluating sintilimab plus chemotherapy for converting unresectable stage IIIB-IIIC non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
A registry update for a real-world study of first-line tislelizumab in advanced non-small cell lung cancer, evaluating treatment strategies …
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
This clinical trial update reports a Phase 2 study evaluating BL-B01D1 in combination with osimertinib for locally advanced or metastatic no…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis [Phase 3]
Phase 3 clinical trial update for a nanocrystalline megestrol acetate formulation aiming to improve appetite and weight in treatment-naive p…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer [Phase 2]
Phase 2 trial investigating danvatirsen in combination with durvalumab for advanced and refractory colorectal cancer, pancreatic cancer, and…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations [Phase 3]
This clinical trial update describes a Phase 3 umbrella trial of adjuvant therapies for completely resected high-risk stage IA-IB non-small …
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases [Phase 2]
Phase 2 clinical trial update on Sacituzumab Govitecan in combination with Bevacizumab for non-small cell lung cancer with brain metastases.…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC [Phase 3]
This clinical trial update describes a Phase 3 study evaluating personalized escalation of consolidation therapy after chemoradiotherapy and…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma [Phase 2]
A Phase 2 trial is evaluating biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy (SBRT) in combination wit…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung) [Phase 2]
A Phase 2 trial (SOURCE Lung) evaluating stereotactic ablative radiotherapy for ultracentral lung tumors, including non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is curren…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer [NA]
A clinical trial update indicates recruitment is ongoing to test whether immunonutrition can enhance the effectiveness of immunotherapy in m…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
This clinical trial update investigates whether the neutrophil to CD4+/CD8+ T-cell ratio can prognosticate outcomes in patients with advance…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CHS-006 in combination with toripalimab for advanced solid tumors, including non-small cell lung cancer, has been…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer
A prospective clinical trial assessing how sleep disturbances and circadian rhythm affect immunotherapy outcomes in patients with non-small …
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Exercise as Maintenance Therapy in Advanced Lung Cancer [NA]
A clinical trial update noting recruitment for a study of exercise as maintenance therapy in advanced lung cancer, including non-small cell …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors [Phase 2]
A Phase 2 clinical trial is evaluating stereotactic body radiotherapy for oligo-residual non-small cell lung cancer after prior treatment wi…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC [Phase 1, Phase 2]
An ongoing Phase 1/2 trial evaluating the IN10018 combination therapy for advanced EGFR mutation-positive non-small cell lung cancer is curr…